论文部分内容阅读
目的探讨甲维比治疗脂肪肝的疗效。方法时30例脂肪肝病人使用甲维比8毫升加入5%葡萄糖250毫升中每日静点,4周为一疗程。同时口服堆生素C和堆生素E,现察治疗前后肝功、血脂变化情况。观察症状改善情况和治疗前后影像学变化。结果乏力、度胀、肝区不适经治疗后减轻和消失者占92%(23/25)。肝功ALT(谷丙转氨酶)由治疗前103.3+ 88.9U/L,降为69.8+34.1U/L,GGT(谷氨酸转肽酶)由治疗前121±S4.7 U/L降为97.4±50.6U/L,甘油三脂(TG)由治疗前2.7±1.3mmol/L降至1.49±0.7mmol/L,肝肿大回缩率35.4%。脾脏肿大回缩者占10%。结论甲维比在脂肪肝治疗中有良好效果,值得在临床中推广应用。
Objective To investigate the curative effect of metopigin on fatty liver. Methods 30 cases of fatty liver patients with carbaryl 8 ml 5% glucose 250 ml daily static point, 4 weeks for a course of treatment. At the same time oral pheromone C and pheromone E, were observed before and after treatment of liver function, blood lipid changes. Observe the improvement of symptoms and imaging changes before and after treatment. The results of fatigue, degree of swelling, liver discomfort after treatment, reduction and disappearance accounted for 92% (23/25). Liver function ALT (alanine aminotransferase) decreased from 103.3 + 88.9U / L before treatment to 69.8 + 34.1U / L, and GGT (glutamate peptidase) decreased from 121 ± S4.7U / L before treatment to 97.4 ± 50.6U / L, triglyceride (TG) decreased from 2.7 ± 1.3mmol / L before treatment to 1.49 ± 0.7mmol / L, hepatomegaly retraction rate was 35.4%. Splenomegaly contraction accounted for 10%. Conclusion Vivalive treatment of fatty liver has a good effect, it is worth to promote the clinical application.